Astellas Pharma
ALPMYDrugs in Pipeline
193
Phase 3 Programs
120
Upcoming Catalysts
2
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
2 upcoming, 1 past
OPT-80
Clostridium Difficile
Setidegrasib
Pancreatic Cancer
daclizumab
Kidney Transplantation
ASP8825
Restless Legs Syndrome
DPP-4 inhibitor
Type 2 Diabetes Mellitus
YM060
Irritable Bowel Syndrome
Enzalutamide
Progressive Metastatic Prostate Cancer
Cyclosporine
Heart Diseases
fluconazole
Invasive Candidiasis
ASP1585
Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
Certolizumab pegol
Rheumatoid Arthritis
ASP1941
Type 2 Diabetes Mellitus
Tacrolimus Cream
Psoriasis
YM150
Arthroplasty, Replacement, Knee
tacrolimus ointment
Dermatitis, Atopic
FK949E
Bipolar Disorder
CDP870
Active Rheumatoid Arthritis
linaclotide
Irritable Bowel Syndrome With Constipation (IBS-C)
Prograf
Liver Transplantation
Goserelin
Prostate Cancer
isavuconazole
Aspergillosis
prednisone
Metastatic Castration-Resistant Prostate Cancer
FK506
Keratoconjunctivitis
metformin
Type II Diabetes Mellitus
tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)
Lower Urinary Tract Symptoms
MMF
Kidney Transplantation
OSI-906
Adrenocortical Carcinoma
Gilteritinib
Advanced Solid Tumors
peficitinib
Psoriasis
FK199B
Sleep Initiation and Maintenance Disorders
tamsulosin hydrochloride OCAS 0.4 mg
Benign Prostatic Hyperplasia
caspofungin
Candidiasis, Oral
degarelix
Prostatic Neoplasms
enoxaparin
Venous Thromboembolism
Pembrolizumab
Urothelial Cancer
YM443
Indigestion
Solifenacin succinate suspension
Urinary Bladder, Overactive
Docetaxel
Metastatic Castration Resistant Prostate Cancer
Tacrolimus capsule
Myasthenia Gravis
Tacrolimus ointment 0.1%
Dermatitis, Atopic
mirabegron 25 mg
Urinary Bladder Diseases
basiliximab
Kidney Transplantation
tolterodine ER
Urinary Bladder, Overactive
Corticosteroids
Liver Transplantation
regadenoson
Coronary Artery Disease (CAD)
Ipragliflozin L-proline
Type 2 Diabetes Mellitus
Sevelamer hydrochloride
Hyperphosphatemia
oxaliplatin
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
Tamoxifen
Hot Flashes
cyclosporine microemulsion
Kidney Transplantation
MR4
Kidney Transplantation
Tamuslosin
Urinary Tract Diseases
LoDAC (Low Dose Cytarabine)
Leukemia, Acute Myeloid (AML)
Interferon alfacon-1
Hepatitis C
Sulfonylurea
Type 2 Diabetes Mellitus
DA
Chronic Kidney Disease
methylprednisolone and prednisone
Kidney Transplantation
Tacrolimus capsules
Lupus Nephritis
overencapsulated caffeine
Coronary Artery Disease (CAD)
Tamusulosin
Urinary Tract Diseases
Etanercept
Rheumatoid Arthritis
QUTENZA
Painful Diabetic Peripheral Neuropathy (PDPN)
Paclitaxel
Ovarian Cancer
Plaebo
Rheumatoid Arthritis (RA)
FK506MR capsule
Liver Transplantation
Voriconazole
Aspergillosis
Tacrolimus, modified release
Kidney Transplantation
FK506E
Heart Transplantation
Alefacept
Psoriatic Arthritis
Epoetin alfa
Anemia
Exisulind
NSCLC
Enfortumab vedotin
Metastatic Urothelial Cancer
Fidaxomicin oral suspension
Clostridium Difficile-associated Diarrhea (CDAD)
Cisplatin
Urothelial Cancer
ASP2138
Gastric Adenocarcinoma
Capecitabine
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
YM177
Post Operative Pain
micafungin (Mycamine)
Fungemia
VESIcare®
Urinary Bladder, Overactive
CZP
Rheumatoid Arthritis
Liposomal Amphotericin B
Candidiasis
YM529 / ONO-5920
Osteoporosis
Ramosetron
Vomiting
Advagraf
Heart Transplantation
mycophenolate mofetil
KIDNEY TRANSPLANTATION
FK506MR
Kidney Transplantation
Simulect
Kidney Transplantation
Prograf-XL
Liver Transplantation
Zolpidem MR
Sleep Initiation and Maintenance Disorders
Methotrexate
Rheumatoid Arthritis
alpha glucosidase inhibitor
Type 2 Diabetes Mellitus
leuprorelin acetate
Prostate Cancer
Pioglitazone
Type 2 Diabetes Mellitus
Tacrolimus modified-release
Liver Transplantation
zolbetuximab
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
Steroids
De Novo Kidney Transplantation
Androgen deprivation therapy (ADT)
Metastatic Hormone Sensitive Prostate Cancer
Tacrolimus (Prograf®)
Rheumatoid Arthritis
nitrazepam
Sleep Initiation and Maintenance Disorders
FK506E (modified release tacrolimus)
Liver Transplantation
Famotidine
Gastroesophageal Reflux
avacincaptad pegol
Geographic Atrophy
azacitidine
Acute Myeloid Leukemia (AML)
febuxostat
Gout
Capsaicin 8%
Diabetic Peripheral Neuropathy
Cytarabine
AML With FLT3 Mutation
Tacrolimus
Asthma, Bronchial
Mirabegron
Neurogenic Detrusor Overactivity
Micafungin
Candidiasis, Oral
ipragliflozin
Diabetes Mellitus
RSD1235
Atrial Fibrillation
ASP0113
Allogeneic Hematopoietic Cell Transplant
pudexacianinium chloride
Intraoperative Ureter Visualization
roxadustat
Hemodialysis Chronic Kidney Disease Patients With Anemia
tolterodine
Urinary Bladder, Overactive
Solifenacin succinate
Urinary Bladder, Overactive
YM178
Urinary Bladder, Overactive
nateglinide
Type 2 Diabetes Mellitus
Darbepoetin alfa
Anemia in Chronic Kidney Disease in Non-dialysis Patients
Fezolinetant
Hot Flashes
ASP1650
Incurable Platinum Refractory Germ Cell Tumors
tacrolimus modified release (MR)
Liver Transplantation
ASP7962
Osteoarthritis of the Knee
Erlotinib
NSCLC
quetiapine extended release (XR)
Major Depressive Disorder
Tacrolimus Ointment 0.03%
Dermatitis, Atopic
YM872 (zonampanel), t-PA (alteplase)
Acute Ischemic Stroke
ASP8302
Underactive Bladder
ASP4070
Rhinitis, Allergic, Seasonal
ASP4901
Benign Prostate Hyperplasia
Tacrolimus Inhalation Aerosol
Asthma
ASP2998
Locally Advanced or Metastatic Malignant Solid Tumors
ASP2246
Chronic Ischemic Stroke
ASP3652
Chronic Abacterial Prostatitis
ASP1128
Acute Kidney Injury (AKI)
ASP5541
Prostate Cancer
warfarin
Atrial Fibrillation
linsitinib
Advanced Solid Tumors
ASP2151
Herpes Genitalis
ASP8062
Fibromyalgia
ASP8477
Post-Herpetic Neuralgia (PHN)
epirubicin
CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction
ASP9831
Non-Alcoholic Steatohepatitis
Isavuconazonium sulfate
Invasive Mucormycosis
FK788
Hepatitis C
OSI-461
Chronic Lymphocytic Leukemia
AGS-1C4D4
Carcinoma, Pancreatic Ductal
AGS-16C3F
Metastatic Renal Cell Carcinoma
ASP1707
Endometriosis
ASP1517
Anemia in Chronic Kidney Disease Patients Not on Dialysis
abiraterone acetate
Prostate Cancer
ASP7517
Acute Myeloid Leukemia (AML)
MA09-hRPE
Stargardt's Macular Dystrophy
ASP7991
Secondary Hyperparathyroidism
YM 155
Prostate Cancer
Reldesemtiv
Chronic Obstructive Pulmonary Disease (COPD)
OSI-211 (Liposomal Lurtotecan)
SCLC
ASP5094
Rheumatoid Arthritis (RA)
ASP0819
Fibromyalgia
ASP4345
Schizophrenia
FK614
Diabetes Mellitus
ASKP1240
Psoriasis
Bleselumab
Kidney Transplantation
steroids, monoclonal anti-IL2R antibody
Hepatitis C
ASP8232
Diabetes Mellitus
YM872 (zonampanel)
Cerebrovascular Accident
YM543
Diabetes Mellitus Type 2
nab-paclitaxel
Pancreatic Cancer
MDV3100
Prostate Cancer
Idarubicin
Acute Myeloid Leukemia
enfortumab vedotin (EV)
Carcinoma, Transitional Cell
leucovorin
Pharmacokinetics of Zolbetuximab
ASP3550
Prostatic Neoplasms
Venetoclax
Acute Myeloid Leukemia (AML)
hydrocortisone acetate ointment 1%
Atopic Dermatitis
CP-461
Crohn's Disease
Methylprednisolone
X-Linked Myotubular Myopathy
Mycophenolate Mofetil (MMF)
Kidney Transplantation
Tacrolimus prolonged release
Intestine Transplantation
bicalutamide
Prostatic Neoplasms
ASK8007
Rheumatoid Arthritis
ASP1570
Advanced Solid Tumors
ASP0456
Chronic Constipation
YM155
Lung Cancer
Valacyclovir hydrochloride
Herpes Zoster
FK463
Candidiasis
Anti-IL2R AB
Liver Transplantation
VCL-CB01
Acute Lymphoblastic Leukemia
Midazolam
Acute Myeloid Leukemia
ASP6294
Bladder Pain Syndrome
FK778
Kidney Transplantation
tamsulosin hydrochloride
Lower Urinary Tract Symptoms
ASP546C
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
OPT-80 | Phase 3 | Clostridium Difficile | - | - |
Setidegrasib | Phase 3 | Pancreatic Cancer | - | - |
daclizumab | Phase 3 | Kidney Transplantation | - | - |
ASP8825 | Phase 3 | Restless Legs Syndrome | - | - |
DPP-4 inhibitor | Phase 3 | Type 2 Diabetes Mellitus | - | - |
YM060 | Phase 3 | Irritable Bowel Syndrome | - | - |
Enzalutamide | Phase 3 | Progressive Metastatic Prostate Cancer | - | - |
Cyclosporine | Phase 3 | Heart Diseases | - | - |
fluconazole | Phase 3 | Invasive Candidiasis | - | - |
ASP1585 | Phase 3 | Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia | - | - |
Certolizumab pegol | Phase 3 | Rheumatoid Arthritis | - | - |
ASP1941 | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Tacrolimus Cream | Phase 3 | Psoriasis | - | - |
YM150 | Phase 3 | Arthroplasty, Replacement, Knee | - | - |
tacrolimus ointment | Phase 3 | Dermatitis, Atopic | - | - |
FK949E | Phase 3 | Bipolar Disorder | - | - |
CDP870 | Phase 3 | Active Rheumatoid Arthritis | - | - |
linaclotide | Phase 3 | Irritable Bowel Syndrome With Constipation (IBS-C) | - | - |
Prograf | Phase 3 | Liver Transplantation | - | - |
Goserelin | Phase 3 | Prostate Cancer | - | - |
isavuconazole | Phase 3 | Aspergillosis | - | - |
prednisone | Phase 3 | Metastatic Castration-Resistant Prostate Cancer | - | - |
FK506 | Phase 3 | Keratoconjunctivitis | - | - |
metformin | Phase 3 | Type II Diabetes Mellitus | - | - |
tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg) | Phase 3 | Lower Urinary Tract Symptoms | - | - |
MMF | Phase 3 | Kidney Transplantation | - | - |
OSI-906 | Phase 3 | Adrenocortical Carcinoma | - | - |
Gilteritinib | Phase 3 | Advanced Solid Tumors | - | - |
peficitinib | Phase 3 | Psoriasis | - | - |
FK199B | Phase 3 | Sleep Initiation and Maintenance Disorders | - | - |
tamsulosin hydrochloride OCAS 0.4 mg | Phase 3 | Benign Prostatic Hyperplasia | - | - |
caspofungin | Phase 3 | Candidiasis, Oral | - | - |
degarelix | Phase 3 | Prostatic Neoplasms | - | - |
enoxaparin | Phase 3 | Venous Thromboembolism | - | - |
Pembrolizumab | Phase 3 | Urothelial Cancer | - | - |
YM443 | Phase 3 | Indigestion | - | - |
Solifenacin succinate suspension | Phase 3 | Urinary Bladder, Overactive | - | - |
Docetaxel | Phase 3 | Metastatic Castration Resistant Prostate Cancer | - | - |
Tacrolimus capsule | Phase 3 | Myasthenia Gravis | - | - |
Tacrolimus ointment 0.1% | Phase 3 | Dermatitis, Atopic | - | - |
mirabegron 25 mg | Phase 3 | Urinary Bladder Diseases | - | - |
basiliximab | Phase 3 | Kidney Transplantation | - | - |
tolterodine ER | Phase 3 | Urinary Bladder, Overactive | - | - |
Corticosteroids | Phase 3 | Liver Transplantation | - | - |
regadenoson | Phase 3 | Coronary Artery Disease (CAD) | - | - |
Ipragliflozin L-proline | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Sevelamer hydrochloride | Phase 3 | Hyperphosphatemia | - | - |
oxaliplatin | Phase 3 | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | - | - |
Tamoxifen | Phase 3 | Hot Flashes | - | - |
cyclosporine microemulsion | Phase 3 | Kidney Transplantation | - | - |
MR4 | Phase 3 | Kidney Transplantation | - | - |
Tamuslosin | Phase 3 | Urinary Tract Diseases | - | - |
LoDAC (Low Dose Cytarabine) | Phase 3 | Leukemia, Acute Myeloid (AML) | - | - |
Interferon alfacon-1 | Phase 3 | Hepatitis C | - | - |
Sulfonylurea | Phase 3 | Type 2 Diabetes Mellitus | - | - |
DA | Phase 3 | Chronic Kidney Disease | - | - |
methylprednisolone and prednisone | Phase 3 | Kidney Transplantation | - | - |
Tacrolimus capsules | Phase 3 | Lupus Nephritis | - | - |
overencapsulated caffeine | Phase 3 | Coronary Artery Disease (CAD) | - | - |
Tamusulosin | Phase 3 | Urinary Tract Diseases | - | - |
Etanercept | Phase 3 | Rheumatoid Arthritis | - | - |
QUTENZA | Phase 3 | Painful Diabetic Peripheral Neuropathy (PDPN) | - | - |
Paclitaxel | Phase 3 | Ovarian Cancer | - | - |
Plaebo | Phase 3 | Rheumatoid Arthritis (RA) | - | - |
FK506MR capsule | Phase 3 | Liver Transplantation | - | - |
Voriconazole | Phase 3 | Aspergillosis | - | - |
Tacrolimus, modified release | Phase 3 | Kidney Transplantation | - | - |
FK506E | Phase 3 | Heart Transplantation | - | - |
Alefacept | Phase 3 | Psoriatic Arthritis | - | - |
Epoetin alfa | Phase 3 | Anemia | - | - |
Exisulind | Phase 3 | NSCLC | - | - |
Enfortumab vedotin | Phase 3 | Metastatic Urothelial Cancer | - | - |
Fidaxomicin oral suspension | Phase 3 | Clostridium Difficile-associated Diarrhea (CDAD) | - | - |
Cisplatin | Phase 3 | Urothelial Cancer | - | - |
ASP2138 | Phase 3 | Gastric Adenocarcinoma | - | - |
Capecitabine | Phase 3 | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | - | - |
YM177 | Phase 3 | Post Operative Pain | - | - |
micafungin (Mycamine) | Phase 3 | Fungemia | - | - |
VESIcare® | Phase 3 | Urinary Bladder, Overactive | - | - |
CZP | Phase 3 | Rheumatoid Arthritis | - | - |
Liposomal Amphotericin B | Phase 3 | Candidiasis | - | - |
YM529 / ONO-5920 | Phase 3 | Osteoporosis | - | - |
Ramosetron | Phase 3 | Vomiting | - | - |
Advagraf | Phase 3 | Heart Transplantation | - | - |
mycophenolate mofetil | Phase 3 | KIDNEY TRANSPLANTATION | - | - |
FK506MR | Phase 3 | Kidney Transplantation | - | - |
Simulect | Phase 3 | Kidney Transplantation | - | - |
Prograf-XL | Phase 3 | Liver Transplantation | - | - |
Zolpidem MR | Phase 3 | Sleep Initiation and Maintenance Disorders | - | - |
Methotrexate | Phase 3 | Rheumatoid Arthritis | - | - |
alpha glucosidase inhibitor | Phase 3 | Type 2 Diabetes Mellitus | - | - |
leuprorelin acetate | Phase 3 | Prostate Cancer | - | - |
Pioglitazone | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Tacrolimus modified-release | Phase 3 | Liver Transplantation | - | - |
zolbetuximab | Phase 3 | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | - | - |
Steroids | Phase 3 | De Novo Kidney Transplantation | - | - |
Androgen deprivation therapy (ADT) | Phase 3 | Metastatic Hormone Sensitive Prostate Cancer | - | - |
Tacrolimus (Prograf®) | Phase 3 | Rheumatoid Arthritis | - | - |
nitrazepam | Phase 3 | Sleep Initiation and Maintenance Disorders | - | - |
FK506E (modified release tacrolimus) | Phase 3 | Liver Transplantation | - | - |
Famotidine | Phase 3 | Gastroesophageal Reflux | - | - |
avacincaptad pegol | Phase 3 | Geographic Atrophy | - | - |
azacitidine | Phase 3 | Acute Myeloid Leukemia (AML) | - | - |
febuxostat | Phase 3 | Gout | - | - |
Capsaicin 8% | Phase 3 | Diabetic Peripheral Neuropathy | - | - |
Cytarabine | Phase 3 | AML With FLT3 Mutation | - | - |
Tacrolimus | Phase 3 | Asthma, Bronchial | - | - |
Mirabegron | Phase 3 | Neurogenic Detrusor Overactivity | - | - |
Micafungin | Phase 3 | Candidiasis, Oral | - | - |
ipragliflozin | Phase 3 | Diabetes Mellitus | - | - |
RSD1235 | Phase 3 | Atrial Fibrillation | - | - |
ASP0113 | Phase 3 | Allogeneic Hematopoietic Cell Transplant | - | - |
pudexacianinium chloride | Phase 3 | Intraoperative Ureter Visualization | - | - |
roxadustat | Phase 3 | Hemodialysis Chronic Kidney Disease Patients With Anemia | - | - |
tolterodine | Phase 3 | Urinary Bladder, Overactive | - | - |
Solifenacin succinate | Phase 3 | Urinary Bladder, Overactive | - | - |
YM178 | Phase 3 | Urinary Bladder, Overactive | - | - |
nateglinide | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Darbepoetin alfa | Phase 3 | Anemia in Chronic Kidney Disease in Non-dialysis Patients | - | - |
Fezolinetant | Phase 3 | Hot Flashes | - | - |
ASP1650 | Phase 2 | Incurable Platinum Refractory Germ Cell Tumors | - | - |
tacrolimus modified release (MR) | Phase 2 | Liver Transplantation | - | - |
ASP7962 | Phase 2 | Osteoarthritis of the Knee | - | - |
Erlotinib | Phase 2 | NSCLC | - | - |
quetiapine extended release (XR) | Phase 2 | Major Depressive Disorder | - | - |
Tacrolimus Ointment 0.03% | Phase 2 | Dermatitis, Atopic | - | - |
YM872 (zonampanel), t-PA (alteplase) | Phase 2 | Acute Ischemic Stroke | - | - |
ASP8302 | Phase 2 | Underactive Bladder | - | - |
ASP4070 | Phase 2 | Rhinitis, Allergic, Seasonal | - | - |
ASP4901 | Phase 2 | Benign Prostate Hyperplasia | - | - |
Tacrolimus Inhalation Aerosol | Phase 2 | Asthma | - | - |
ASP2998 | Phase 2 | Locally Advanced or Metastatic Malignant Solid Tumors | - | - |
ASP2246 | Phase 2 | Chronic Ischemic Stroke | - | - |
ASP3652 | Phase 2 | Chronic Abacterial Prostatitis | - | - |
ASP1128 | Phase 2 | Acute Kidney Injury (AKI) | - | - |
ASP5541 | Phase 2 | Prostate Cancer | - | - |
warfarin | Phase 2 | Atrial Fibrillation | - | - |
linsitinib | Phase 2 | Advanced Solid Tumors | - | - |
ASP2151 | Phase 2 | Herpes Genitalis | - | - |
ASP8062 | Phase 2 | Fibromyalgia | - | - |
ASP8477 | Phase 2 | Post-Herpetic Neuralgia (PHN) | - | - |
epirubicin | Phase 2 | CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | - | - |
ASP9831 | Phase 2 | Non-Alcoholic Steatohepatitis | - | - |
Isavuconazonium sulfate | Phase 2 | Invasive Mucormycosis | - | - |
FK788 | Phase 2 | Hepatitis C | - | - |
OSI-461 | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
AGS-1C4D4 | Phase 2 | Carcinoma, Pancreatic Ductal | - | - |
AGS-16C3F | Phase 2 | Metastatic Renal Cell Carcinoma | - | - |
ASP1707 | Phase 2 | Endometriosis | - | - |
ASP1517 | Phase 2 | Anemia in Chronic Kidney Disease Patients Not on Dialysis | - | - |
abiraterone acetate | Phase 2 | Prostate Cancer | - | - |
ASP7517 | Phase 2 | Acute Myeloid Leukemia (AML) | - | - |
MA09-hRPE | Phase 2 | Stargardt's Macular Dystrophy | - | - |
ASP7991 | Phase 2 | Secondary Hyperparathyroidism | - | - |
YM 155 | Phase 2 | Prostate Cancer | - | - |
Reldesemtiv | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
OSI-211 (Liposomal Lurtotecan) | Phase 2 | SCLC | - | - |
ASP5094 | Phase 2 | Rheumatoid Arthritis (RA) | - | - |
ASP0819 | Phase 2 | Fibromyalgia | - | - |
ASP4345 | Phase 2 | Schizophrenia | - | - |
FK614 | Phase 2 | Diabetes Mellitus | - | - |
ASKP1240 | Phase 2 | Psoriasis | - | - |
Bleselumab | Phase 2 | Kidney Transplantation | - | - |
steroids, monoclonal anti-IL2R antibody | Phase 2 | Hepatitis C | - | - |
ASP8232 | Phase 2 | Diabetes Mellitus | - | - |
YM872 (zonampanel) | Phase 2 | Cerebrovascular Accident | - | - |
YM543 | Phase 2 | Diabetes Mellitus Type 2 | - | - |
nab-paclitaxel | Phase 2 | Pancreatic Cancer | - | - |
MDV3100 | Phase 2 | Prostate Cancer | - | - |
Idarubicin | Phase 2 | Acute Myeloid Leukemia | - | - |
enfortumab vedotin (EV) | Phase 2 | Carcinoma, Transitional Cell | - | - |
leucovorin | Phase 2 | Pharmacokinetics of Zolbetuximab | - | - |
ASP3550 | Phase 2 | Prostatic Neoplasms | - | - |
Venetoclax | Phase 2 | Acute Myeloid Leukemia (AML) | - | - |
hydrocortisone acetate ointment 1% | Phase 2 | Atopic Dermatitis | - | - |
CP-461 | Phase 2 | Crohn's Disease | - | - |
Methylprednisolone | Phase 2 | X-Linked Myotubular Myopathy | - | - |
Mycophenolate Mofetil (MMF) | Phase 2 | Kidney Transplantation | - | - |
Tacrolimus prolonged release | Phase 2 | Intestine Transplantation | - | - |
bicalutamide | Phase 2 | Prostatic Neoplasms | - | - |
ASK8007 | Phase 2 | Rheumatoid Arthritis | - | - |
ASP1570 | Phase 2 | Advanced Solid Tumors | - | - |
ASP0456 | Phase 2 | Chronic Constipation | - | - |
YM155 | Phase 2 | Lung Cancer | - | - |
Valacyclovir hydrochloride | Phase 2 | Herpes Zoster | - | - |
FK463 | Phase 2 | Candidiasis | - | - |
Anti-IL2R AB | Phase 2 | Liver Transplantation | - | - |
VCL-CB01 | Phase 2 | Acute Lymphoblastic Leukemia | - | - |
Midazolam | Phase 2 | Acute Myeloid Leukemia | - | - |
ASP6294 | Phase 2 | Bladder Pain Syndrome | - | - |
FK778 | Phase 2 | Kidney Transplantation | - | - |
tamsulosin hydrochloride | Phase 2 | Lower Urinary Tract Symptoms | - | - |
ASP546C | Phase 2 | Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma | - | - |
geographic atrophy
1 drug in this indication
Pancreatic Cancer
1 drug in this indication
Clostridium Difficile
1 drug in this indication
Kidney Transplantation
1 drug in this indication
Incurable Platinum Refractory Germ Cell Tumors
1 drug in this indication
Post Operative Pain
1 drug in this indication
Fungemia
1 drug in this indication
NSCLC
1 drug in this indication
Major Depressive Disorder
1 drug in this indication
Urinary Bladder, Overactive
1 drug in this indication
Acute Ischemic Stroke
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Astellas Pharma's drug pipeline?→
CatalystAlert tracks 193 drug candidates in Astellas Pharma's (ALPMY) pipeline across Phase 3, Phase 2. Its lead program is OPT-80 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Astellas Pharma's next FDA catalyst?→
Astellas Pharma's (ALPMY) next tracked catalyst is a Phase 2 expected August 31, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ALPMY biotech catalysts?→
Add ALPMY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Astellas Pharma's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.